lenalidomide has been researched along with Chronic Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gonsalves, WI; Lam, S; M Saunders, I; Momper, JD; Salama, E; Tzachanis, D | 1 |
| Engelhardt, M; Grünewald, J; Ihorst, G; Kleber, M; Reinhardt, H; Schmidts, A; Terpos, E; Walz, G; Wäsch, R; Zschiedrich, S | 1 |
3 other study(ies) available for lenalidomide and Chronic Kidney Diseases
| Article | Year |
|---|---|
Estimation of Kidney Function in Patients With Multiple Myeloma: Implications for Lenalidomide Dosing.
Topics: Body Weight; Creatinine; Glomerular Filtration Rate; Humans; Kidney; Lenalidomide; Multiple Myeloma; Renal Insufficiency, Chronic | 2023 |
[Expert consensus for the diagnosis and treatment of patients with renal impairment of multiple myeloma].
Topics: Consensus; Creatinine; Dexamethasone; Glomerular Filtration Rate; Humans; Immunoglobulin Light Chains; Lenalidomide; Male; Multiple Myeloma; Renal Dialysis; Renal Insufficiency; Renal Insufficiency, Chronic; Thalidomide | 2017 |
GFR estimation in lenalidomide treatment of multiple myeloma patients: a prospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers; Creatinine; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Kidney; Lenalidomide; Male; Middle Aged; Models, Biological; Multiple Myeloma; Prospective Studies; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2019 |